Literature DB >> 21529287

Generation and characterization of anti-chitinase monoclonal antibodies.

Mohammad Soukhtanloo1, Reza Falak, Mojtaba Sankian, A-Reza Varasteh.   

Abstract

Class IV chitinase, an allergenic protein of Vitis vinifera (grape), was purified by anion exchange chromatography and used for immunization of Balb/c mice. Monoclonal antibodies (MAbs) were raised by hybridoma technology using Sp2/0 myeloma cells. Finally after three limiting dilutions, six stable clones were generated. Antibody isotyping showed that IgG(2a), IgG(2b), and IgM were produced by one, two, and three of the clones, respectively. All of the MAbs had kappa light chain. The affinities were in the range of 3 × 10(8) to 1.2 × 10(9) M(-1). The MAbs were specific for grape chitinase as confirmed by Western blotting. In conclusion, we successfully produced several MAbs against grape class IV chitinase, which could be used for assessment of this allergen in different grape cultivars.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21529287     DOI: 10.1089/hyb.2010.0088

Source DB:  PubMed          Journal:  Hybridoma (Larchmt)        ISSN: 1554-0014


  3 in total

1.  Refolding process of cysteine-rich proteins:Chitinase as a model.

Authors:  Malihe Moghadam; Ali Ganji; Abdolreza Varasteh; Reza Falak; Mojtaba Sankian
Journal:  Rep Biochem Mol Biol       Date:  2015-10

2.  Graphene oxide attenuates Th2-type immune responses, but augments airway remodeling and hyperresponsiveness in a murine model of asthma.

Authors:  Michael R Shurin; Naveena Yanamala; Elena R Kisin; Alexey V Tkach; Galina V Shurin; Ashley R Murray; Howard D Leonard; Jeffrey S Reynolds; Dmirtiy W Gutkin; Alexander Star; Bengt Fadeel; Kai Savolainen; Valerian E Kagan; Anna A Shvedova
Journal:  ACS Nano       Date:  2014-05-23       Impact factor: 15.881

3.  Induction of humoral immune responses and inhibition of metastasis in mice by a VEGF peptide-based vaccine.

Authors:  Faezeh Soltanpour Gharibdousti; Banafsheh Fazeli Delshad; Reza Falak; Nasrin Shayanfar; Mazdak Ganjalikhani Hakemi; Alireza Andalib; Gholam Ali Kardar
Journal:  Iran J Basic Med Sci       Date:  2020-04       Impact factor: 2.699

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.